跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
META-IODOBENZYLGUANIDINE (I-131) INJECTION FOR THERAPEUTIC USE - HSA Drug Approval Details
Approvals
/
HSA
/
META-IODOBENZYLGUANIDINE (I-131) INJECTION FOR THERAPEUTIC USE
Approved
STANDARD
META-IODOBENZYLGUANIDINE (I-131) INJECTION FOR THERAPEUTIC USE
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
6b30c1e2ec0804af
Company
Unknown
Type
Standard
Approval Details
Approval Id
6b30c1e2ec0804af
Drug Name
META-IODOBENZYLGUANIDINE (I-131) INJECTION FOR THERAPEUTIC USE
Active Ingredients
META-IODOBENZYLGUANIDINE (I-131)
0.185 - 0.740 GBq/ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
6b30c1e2ec0804af
Type
Standard
Back to HSA Approvals
